{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T04:17:47Z","timestamp":1776745067116,"version":"3.51.2"},"reference-count":117,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","jctejournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical & Translational Endocrinology"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.jcte.2021.100289","type":"journal-article","created":{"date-parts":[[2021,12,5]],"date-time":"2021-12-05T22:30:36Z","timestamp":1638743436000},"page":"100289","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Gestational and pregestational diabetes in pregnant women with cystic fibrosis"],"prefix":"10.1016","volume":"27","author":[{"given":"Rachael","family":"Oxman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea H.","family":"Roe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jagdeesh","family":"Ullal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa S.","family":"Putman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcte.2021.100289_b0005","first-page":"92","volume":"2019","author":"Cystic Fibrosis Foundation","year":"2019","journal-title":"Patient Registry Annual Data Report"},{"key":"10.1016\/j.jcte.2021.100289_b0010","doi-asserted-by":"crossref","unstructured":"Elborn JS. Cystic fibrosis. Lancet Lond Engl 2016;388:2519\u201331. https:\/\/doi.org\/10.1016\/S0140-6736(16)00576-6.","DOI":"10.1016\/S0140-6736(16)00576-6"},{"issue":"19","key":"10.1016\/j.jcte.2021.100289_b0015","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa1908639","article-title":"Elexacaftor-Tezacaftor-Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele","volume":"381","author":"Middleton","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcte.2021.100289_b0020","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1016\/S0140-6736(19)32597-8","article-title":"Efficacy and safety of the elexacaftor\/tezacaftor\/ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial","volume":"394","author":"Heijerman","year":"2019","journal-title":"Lancet Lond Engl"},{"issue":"Suppl 1","key":"10.1016\/j.jcte.2021.100289_b0025","first-page":"25","article-title":"Potential impact on fertility of new systemic therapies for cystic fibrosis","volume":"16","author":"Jones","year":"2015","journal-title":"Paediatr Respir Rev"},{"issue":"98","key":"10.1016\/j.jcte.2021.100289_b0030","first-page":"e1","article-title":"Medical and obstetric complications among pregnant women with cystic fibrosis","volume":"212","author":"Patel","year":"2015","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.jcte.2021.100289_b0035","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1378\/chest.118.1.85","article-title":"Pregnancy in cystic fibrosis. Fetal and maternal outcome","volume":"118","author":"Gilljam","year":"2000","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.jcte.2021.100289_b0040","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/1471-0528.12040","article-title":"The outcome of pregnancies in women with cystic fibrosis\u2013single centre experience 1998\u20132011","volume":"120","author":"Thorpe-Beeston","year":"2013","journal-title":"BJOG Int J Obstet Gynaecol"},{"issue":"8","key":"10.1016\/j.jcte.2021.100289_b0045","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1111\/j.1471-0528.2002.01511.x","article-title":"French Cystic Fibrosis Registry. Cystic fibrosis and pregnancy. Report from French data (1980\u20131999)","volume":"109","author":"Gillet","year":"2002","journal-title":"BJOG Int J Obstet Gynaecol"},{"issue":"3","key":"10.1016\/j.jcte.2021.100289_b0050","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.jcf.2020.09.002","article-title":"Baseline Cystic fibrosis disease severity has an adverse impact on pregnancy and infant outcomes, but does not impact disease progression","volume":"20","author":"Cohen-Cymberknoh","year":"2021","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcte.2021.100289_b0055","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1513\/AnnalsATS.201211-108OC","article-title":"Long-term effects of pregnancy and motherhood on disease outcomes of women with cystic fibrosis","volume":"10","author":"Schechter","year":"2013","journal-title":"Ann Am Thorac Soc"},{"issue":"3","key":"10.1016\/j.jcte.2021.100289_b0060","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1378\/chest.129.3.706","article-title":"Impact of pregnancy on women with cystic fibrosis","volume":"129","author":"McMullen","year":"2006","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.jcte.2021.100289_b0065","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1177\/1753495X14554022","article-title":"Pregnancy and cystic fibrosis: Approach to contemporary management","volume":"7","author":"Geake","year":"2014","journal-title":"Obstet Med"},{"issue":"4","key":"10.1016\/j.jcte.2021.100289_b0070","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1378\/chest.124.4.1460","article-title":"The effect of pregnancy on survival in women with cystic fibrosis","volume":"124","author":"Goss","year":"2003","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.jcte.2021.100289_b0075","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jcf.2013.08.004","article-title":"Cystic fibrosis and pregnancy in the modern era: a case control study","volume":"13","author":"Ahluwalia","year":"2014","journal-title":"J Cyst Fibros Off J Eur Cyst Fibros Soc"},{"issue":"1_suppl","key":"10.1016\/j.jcte.2021.100289_b0080","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1258\/jrsm.2009.s19002","article-title":"Contraception and pregnancy in cystic fibrosis","volume":"102","author":"Thorpe-Beeston","year":"2009","journal-title":"J R Soc Med"},{"issue":"2","key":"10.1016\/j.jcte.2021.100289_b0085","first-page":"113","article-title":"Two successful pregnancies in a woman affected by cystic fibrosis: case report and review of the literature","volume":"25","author":"Ciavattini","year":"2012","journal-title":"J Matern-Fetal Neonatal Med Off J Eur Assoc Perinat Med Fed Asia Ocean Perinat Soc Int Soc Perinat Obstet"},{"issue":"13","key":"10.1016\/j.jcte.2021.100289_b0090","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1111\/1471-0528.16423","article-title":"The outcome of pregnancy in women with cystic fibrosis: a UK population-based descriptive study","volume":"127","author":"Ashcroft","year":"2020","journal-title":"BJOG Int J Obstet Gynaecol"},{"key":"10.1016\/j.jcte.2021.100289_b0095","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1034\/j.1600-0412.2002.810803.x","article-title":"Maternal and fetal morbidity in pregnancies of Norwegian and Swedish women with cystic fibrosis","volume":"81","author":"\u00d8degaard","year":"2002","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"5","key":"10.1016\/j.jcte.2021.100289_b0100","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1136\/thoraxjnl-2018-211706","article-title":"Impact of cystic fibrosis on birthweight: a population based study of children in Denmark and Wales","volume":"74","author":"Schl\u00fcter","year":"2019","journal-title":"Thorax"},{"key":"10.1016\/j.jcte.2021.100289_b0105","doi-asserted-by":"crossref","unstructured":"Lau EMT, Barnes DJ, Moriarty C, Ogle R, Dentice R, Civitico J, et al. Pregnancy outcomes in the current era of cystic fibrosis care: a 15-year experience. Aust N Z J Obstet Gynaecol 2011;51:220\u20134. https:\/\/doi.org\/10.1111\/j.1479-828X.2010.01287.x.","DOI":"10.1111\/j.1479-828X.2010.01287.x"},{"issue":"2","key":"10.1016\/j.jcte.2021.100289_b0110","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ejogrb.2012.06.013","article-title":"Current pregnancy outcomes in women with cystic fibrosis","volume":"164","author":"Burden","year":"2012","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.jcte.2021.100289_b0115","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.rmed.2016.02.010","article-title":"Maternal and perinatal outcomes of pregnancies in women with cystic fibrosis\u2013A single centre case-control study","volume":"113","author":"Girault","year":"2016","journal-title":"Respir Med"},{"key":"10.1016\/j.jcte.2021.100289_b0120","first-page":"95","article-title":"Pregnancies and outcome in women with cystic fibrosis","volume":"7","author":"Barak","year":"2005","journal-title":"Isr Med Assoc J IMAJ"},{"issue":"2","key":"10.1016\/j.jcte.2021.100289_b0125","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/j.1471-0528.2000.tb11697.x","article-title":"The outcome of 72 pregnancies in 55 women with cystic fibrosis in the United Kingdom 1977\u20131996","volume":"107","author":"Edenborough","year":"2000","journal-title":"BJOG Int J Obstet Gynaecol"},{"issue":"2","key":"10.1016\/j.jcte.2021.100289_b0130","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jcf.2006.01.002","article-title":"Aggressive prenatal care results in successful fetal outcomes in CF women","volume":"5","author":"Cheng","year":"2006","journal-title":"J Cyst Fibros"},{"issue":"1","key":"10.1016\/j.jcte.2021.100289_b0135","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3109\/14767058.2016.1161747","article-title":"Maternal co-morbidities and neonatal outcomes associated with cystic fibrosis","volume":"30","author":"Jelin","year":"2017","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"9","key":"10.1016\/j.jcte.2021.100289_b0140","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.2337\/dc09-0586","article-title":"Cystic fibrosis-related diabetes: current trends in prevalence, incidence, and mortality","volume":"32","author":"Moran","year":"2009","journal-title":"Diabetes Care"},{"issue":"Suppl 2","key":"10.1016\/j.jcte.2021.100289_b0145","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.jcf.2019.08.016","article-title":"Cystic fibrosis related diabetes: Pathophysiology, screening and diagnosis","volume":"18","author":"Granados","year":"2019","journal-title":"J Cyst Fibros Off J Eur Cyst Fibros Soc"},{"key":"10.1016\/j.jcte.2021.100289_b0150","doi-asserted-by":"crossref","unstructured":"Zhou T, Sun D, Li X, Heianza Y, Nisa H, Hu G, et al. Prevalence and Trends in Gestational Diabetes Mellitus among Women in the United States, 2006\u20132016. Diabetes 2018;67. https:\/\/doi.org\/10.2337\/db18-121-OR.","DOI":"10.2337\/db18-121-OR"},{"key":"10.1016\/j.jcte.2021.100289_b0155","doi-asserted-by":"crossref","unstructured":"Deputy NP. Prevalence and Changes in Preexisting Diabetes and Gestational Diabetes Among Women Who Had a Live Birth \u2014 United States, 2012\u20132016. MMWR Morb Mortal Wkly Rep 2018;67. https:\/\/doi.org\/10.15585\/mmwr.mm6743a2.","DOI":"10.15585\/mmwr.mm6743a2"},{"issue":"4","key":"10.1016\/j.jcte.2021.100289_b0160","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/ajo.12446","article-title":"Effect of pregnancy on insulin requirements differs between type 1 and type 2 diabetes: A cohort study of 222 pregnancies","volume":"56","author":"Padmanabhan","year":"2016","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"10.1016\/j.jcte.2021.100289_b0165","doi-asserted-by":"crossref","first-page":"3342","DOI":"10.3390\/ijms19113342","article-title":"The pathophysiology of gestational diabetes mellitus","volume":"19","author":"Plows","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jcte.2021.100289_b0170","doi-asserted-by":"crossref","unstructured":"Sonagra AD, Biradar SM, K. D, Murthy D.S. J. Normal Pregnancy- A State of Insulin Resistance. J Clin Diagn Res JCDR 2014;8:CC01\u20133. https:\/\/doi.org\/10.7860\/JCDR\/2014\/10068.5081.","DOI":"10.7860\/JCDR\/2014\/10068.5081"},{"key":"10.1016\/j.jcte.2021.100289_b0175","doi-asserted-by":"crossref","unstructured":"Association AD. 14. Management of Diabetes in Pregnancy: Standards of Medical Care in Diabetes\u20142021. Diabetes Care 2021;44:S200\u201310. https:\/\/doi.org\/10.2337\/dc21-S014.","DOI":"10.2337\/dc21-S014"},{"issue":"2","key":"10.1016\/j.jcte.2021.100289_b0180","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/01.AOG.0000172421.04007.74","article-title":"The metabolic effects of pregnancy in cystic fibrosis","volume":"106","author":"Hardin","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jcte.2021.100289_b0185","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1056\/NEJMoa0707943","article-title":"Hyperglycemia and adverse pregnancy outcomes","volume":"358","author":"HAPO Study Cooperative Research Group","year":"2008","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.jcte.2021.100289_b0190","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1067\/mob.2001.115864","article-title":"Clinical impact of mild carbohydrate intolerance in pregnancy: a study of 2904 nondiabetic Danish women with risk factors for gestational diabetes mellitus","volume":"185","author":"Jensen","year":"2001","journal-title":"Am J Obstet Gynecol"},{"issue":"9","key":"10.1016\/j.jcte.2021.100289_b0195","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.2337\/diacare.25.9.1619","article-title":"Women with impaired glucose tolerance during pregnancy have significantly poor pregnancy outcomes","volume":"25","author":"Yang","year":"2002","journal-title":"Diabetes Care"},{"issue":"10","key":"10.1016\/j.jcte.2021.100289_b0200","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1007\/s00125-019-4943-9","article-title":"Factors associated with stillbirth in women with diabetes","volume":"62","author":"Mackin","year":"2019","journal-title":"Diabetologia"},{"issue":"2","key":"10.1016\/j.jcte.2021.100289_b0205","first-page":"232","article-title":"The association of pregestational and gestational diabetes with severe neonatal morbidity and mortality","volume":"40","author":"Battarbee","year":"2020","journal-title":"J Perinatol Off J Calif Perinat Assoc"},{"issue":"4","key":"10.1016\/j.jcte.2021.100289_b0210","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1007\/s00125-017-4206-6","article-title":"Gestational diabetes and adverse perinatal outcomes from 716,152 births in France in 2012","volume":"60","author":"Billionnet","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/j.jcte.2021.100289_b0215","doi-asserted-by":"crossref","unstructured":"American Diabetes Association. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2020. Diabetes Care 2020;43:S14\u201331. https:\/\/doi.org\/10.2337\/dc20-S002.","DOI":"10.2337\/dc20-S002"},{"issue":"309","key":"10.1016\/j.jcte.2021.100289_b0220","first-page":"e1","article-title":"The risk of stillbirth and infant death stratified by gestational age in women with gestational diabetes","volume":"206","author":"Rosenstein","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jcte.2021.100289_b0225","doi-asserted-by":"crossref","first-page":"481","DOI":"10.4239\/wjd.v6.i3.481","article-title":"Birth defects in pregestational diabetes: Defect range, glycemic threshold and pathogenesis","volume":"6","author":"Gabbay-Benziv","year":"2015","journal-title":"World J Diabetes"},{"issue":"7103","key":"10.1016\/j.jcte.2021.100289_b0230","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1136\/bmj.315.7103.279","article-title":"Prospective population based survey of outcome of pregnancy in diabetic women: results of the Northern Diabetic Pregnancy Audit, 1994","volume":"315","author":"Hawthorne","year":"1997","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.jcte.2021.100289_b0235","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s001250050010","article-title":"Glycaemic control during early pregnancy and fetal malformations in women with type I diabetes mellitus","volume":"43","author":"Suhonen","year":"2000","journal-title":"Diabetologia"},{"key":"10.1016\/j.jcte.2021.100289_b0240","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1136\/bmj.325.7375.1275","article-title":"Association between outcome of pregnancy and glycaemic control in early pregnancy in type 1 diabetes: population based study","volume":"325","author":"Temple","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.jcte.2021.100289_b0245","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1046\/j.1464-5491.2003.01017.x","article-title":"Pregnancy in women with Type 2 diabetes: 12 years outcome data 1990\u20132002","volume":"20","author":"Dunne","year":"2003","journal-title":"Diabet Med J Br Diabet Assoc"},{"issue":"12","key":"10.1016\/j.jcte.2021.100289_b0250","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1055\/s-0041-1730435","article-title":"Congenital Malformation Risk According to Hemoglobin A1c Values in a Contemporary Cohort with Pregestational Diabetes","volume":"38","author":"Martin","year":"2021","journal-title":"Am J Perinatol"},{"issue":"6","key":"10.1016\/j.jcte.2021.100289_b0255","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.2337\/dc08-2061","article-title":"Peri-conceptional A1C and risk of serious adverse pregnancy outcome in 933 women with type 1 diabetes","volume":"32","author":"Jensen","year":"2009","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.jcte.2021.100289_b0260","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1046\/j.1464-5491.2000.00215.x","article-title":"Perinatal mortality in Type 2 diabetes mellitus","volume":"17","author":"Cundy","year":"2000","journal-title":"Diabet Med J Br Diabet Assoc"},{"issue":"10","key":"10.1016\/j.jcte.2021.100289_b0265","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1111\/aogs.13185","article-title":"Pregnancy outcome in women with cystic fibrosis-related diabetes","volume":"96","author":"Reynaud","year":"2017","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"6","key":"10.1016\/j.jcte.2021.100289_b0270","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1097\/AOG.0b013e31826d7eca","article-title":"Effect of maternal cystic fibrosis genotype on diabetes in pregnancy","volume":"120","author":"Giacobbe","year":"2012","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jcte.2021.100289_b0275","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1093\/aje\/kwg273","article-title":"Association between Gestational Diabetes and Pregnancy-induced Hypertension","volume":"158","author":"Bryson","year":"2003","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jcte.2021.100289_b0280","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s11892-015-0579-4","article-title":"Preeclampsia and Diabetes","volume":"15","author":"Weissgerber","year":"2015","journal-title":"Curr Diab Rep"},{"issue":"1","key":"10.1016\/j.jcte.2021.100289_b0285","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ejogrb.2003.07.001","article-title":"Gestational diabetes and preeclampsia","volume":"113","author":"\u00d6stlund","year":"2004","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.jcte.2021.100289_b0290","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1758-5996-4-41","article-title":"Adverse pregnancy outcomes in women with diabetes","volume":"4","author":"Negrato","year":"2012","journal-title":"Diabetol Metab Syndr"},{"issue":"9677","key":"10.1016\/j.jcte.2021.100289_b0295","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/S0140-6736(09)60731-5","article-title":"Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis","volume":"373","author":"Bellamy","year":"2009","journal-title":"Lancet Lond Engl"},{"issue":"6","key":"10.1016\/j.jcte.2021.100289_b0300","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1007\/s00125-015-3537-4","article-title":"Long-term risk of type 2 diabetes mellitus in relation to BMI and weight change among women with a history of gestational diabetes mellitus: a prospective cohort study","volume":"58","author":"Bao","year":"2015","journal-title":"Diabetologia"},{"issue":"8996","key":"10.1016\/j.jcte.2021.100289_b0305","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0140-6736(96)90405-5","article-title":"Long-term diabetogenic effect of single pregnancy in women with previous gestational diabetes mellitus","volume":"347","author":"Peters","year":"1996","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.jcte.2021.100289_b0310","doi-asserted-by":"crossref","first-page":"234","DOI":"10.4239\/wjd.v6.i2.234","article-title":"Type 2 diabetes after gestational diabetes: The influence of changing diagnostic criteria","volume":"6","author":"Noctor","year":"2015","journal-title":"World J Diabetes"},{"issue":"9","key":"10.1016\/j.jcte.2021.100289_b0315","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.2337\/dc05-2482","article-title":"Gestational diabetes mellitus increases the risk of cardiovascular disease in women with a family history of type 2 diabetes","volume":"29","author":"Carr","year":"2006","journal-title":"Diabetes Care"},{"issue":"8","key":"10.1016\/j.jcte.2021.100289_b0320","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.2337\/dc08-0706","article-title":"Increased Risk of Cardiovascular Disease in Young Women Following Gestational Diabetes Mellitus","volume":"31","author":"Shah","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcte.2021.100289_b0325","doi-asserted-by":"crossref","first-page":"144","DOI":"10.3389\/fendo.2017.00144","article-title":"History of Gestational Diabetes Mellitus in Relation to Cardiovascular Disease and Cardiovascular Risk Factors in US Women","volume":"8","author":"Shostrom","year":"2017","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.jcte.2021.100289_b0330","doi-asserted-by":"crossref","unstructured":"Gunderson EP, Chiang V, Pletcher MJ, Jacobs DR, Quesenberry CP, Sidney S, et al. History of Gestational Diabetes Mellitus and Future Risk of Atherosclerosis in Mid\u2010life: The Coronary Artery Risk Development in Young Adults Study. J Am Heart Assoc n.d.;3:e000490. https:\/\/doi.org\/10.1161\/JAHA.113.000490.","DOI":"10.1161\/JAHA.113.000490"},{"key":"10.1016\/j.jcte.2021.100289_b0335","first-page":"92","article-title":"Type 1 Diabetes Mellitus and Pregnancy","volume":"3","author":"Vargas","year":"2010","journal-title":"Rev Obstet Gynecol"},{"issue":"7445","key":"10.1016\/j.jcte.2021.100289_b0340","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1136\/bmj.38043.583160.EE","article-title":"Risk of complications of pregnancy in women with type 1 diabetes: nationwide prospective study in the Netherlands","volume":"328","author":"Evers","year":"2004","journal-title":"BMJ"},{"key":"10.1016\/j.jcte.2021.100289_b0345","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12884-015-0499-y","article-title":"Comparing type 1 and type 2 diabetes in pregnancy- similar conditions or is a separate approach required?","volume":"15","author":"Owens","year":"2015","journal-title":"BMC Pregnancy Childbirth"},{"issue":"12","key":"10.1016\/j.jcte.2021.100289_b0350","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.2337\/diacare.27.12.2819","article-title":"Outcomes in Type 1 Diabetic Pregnancies: A nationwide, population-based study","volume":"27","author":"Jensen","year":"2004","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.jcte.2021.100289_b0355","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1007\/s00125-010-1697-9","article-title":"Progression of diabetic retinopathy during pregnancy in women with type 2 diabetes","volume":"53","author":"Rasmussen","year":"2010","journal-title":"Diabetologia"},{"key":"10.1016\/j.jcte.2021.100289_b0360","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/310239","article-title":"Diabetic retinopathy in pregnancy: a population-based study of women with pregestational diabetes","volume":"2015","author":"Egan","year":"2015","journal-title":"J Diabetes Res"},{"issue":"S1","key":"10.1016\/j.jcte.2021.100289_b0365","first-page":"1","article-title":"Diabetic retinopathy and diabetic macular oedema pathways and management: UK Consensus Working Group","volume":"34","author":"Amoaku","year":"2020","journal-title":"Eye Lond Engl"},{"issue":"1","key":"10.1016\/j.jcte.2021.100289_b0370","doi-asserted-by":"crossref","first-page":"34","DOI":"10.2337\/diacare.13.1.34","article-title":"Effect of pregnancy on progression of diabetic retinopathy","volume":"13","author":"Klein","year":"1990","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.jcte.2021.100289_b0375","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s40620-018-0553-8","article-title":"Pregnancy in women with diabetic nephropathy","volume":"32","author":"Spotti","year":"2019","journal-title":"J Nephrol"},{"key":"10.1016\/j.jcte.2021.100289_b0380","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003104","article-title":"Risk of severe maternal morbidity or death in relation to elevated hemoglobin A1c preconception, and in early pregnancy: A population-based cohort study","volume":"17","author":"Davidson","year":"2020","journal-title":"PLOS Med"},{"key":"10.1016\/j.jcte.2021.100289_b0385","doi-asserted-by":"crossref","unstructured":"Bornstein E, Eliner Y, Chervenak FA, Gr\u00fcnebaum A. Concerning trends in maternal risk factors in the United States: 1989\u20132018. EClinicalMedicine 2020;29. https:\/\/doi.org\/10.1016\/j.eclinm.2020.100657.","DOI":"10.1016\/j.eclinm.2020.100657"},{"key":"10.1016\/j.jcte.2021.100289_b0390","doi-asserted-by":"crossref","first-page":"473","DOI":"10.2337\/dc09-1605","article-title":"Hypoglycemia in Type 1 Diabetic Pregnancy","volume":"33","author":"Heller","year":"2010","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.jcte.2021.100289_b0395","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2337\/dc07-1066","article-title":"Hypoglycemia in Pregnant Women With Type 1 Diabetes: Predictors and role of metabolic control","volume":"31","author":"Nielsen","year":"2008","journal-title":"Diabetes Care"},{"issue":"9","key":"10.1016\/j.jcte.2021.100289_b0400","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.2337\/diacare.28.9.2141","article-title":"Diabetes is associated with dramatically decreased survival in female but not male subjects with cystic fibrosis","volume":"28","author":"Milla","year":"2005","journal-title":"Diabetes Care"},{"issue":"14","key":"10.1016\/j.jcte.2021.100289_b0405","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1056\/NEJMoa0902430","article-title":"A multicenter, randomized trial of treatment for mild gestational diabetes","volume":"361","author":"Landon","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcte.2021.100289_b0410","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1056\/NEJMoa042973","article-title":"Effect of treatment of gestational diabetes mellitus on pregnancy outcomes","volume":"352","author":"Crowther","year":"2005","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.jcte.2021.100289_b0415","doi-asserted-by":"crossref","first-page":"883","DOI":"10.2337\/dc20-2692","article-title":"Association of Implementation of a Comprehensive Preconception-to-Pregnancy Management Plan With Pregnancy Outcomes Among Chinese Pregnant Women With Type 1 Diabetes: The CARNATION Study","volume":"44","author":"Zheng","year":"2021","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.jcte.2021.100289_b0420","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1210\/jc.2015-3817","article-title":"Ten Years of Optimizing Outcomes for Women With Type 1 and Type 2 Diabetes in Pregnancy-The Atlantic DIP Experience","volume":"101","author":"Owens","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.jcte.2021.100289_b0425","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.2337\/dc10-1768","article-title":"Clinical Care Guidelines for Cystic Fibrosis-Related Diabetes: A position statement of the American Diabetes Association and a clinical practice guideline of the Cystic Fibrosis Foundation, endorsed by the Pediatric Endocrine Society","volume":"33","author":"Moran","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcte.2021.100289_b0430","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.jcf.2007.10.001","article-title":"Guidelines for the management of pregnancy in women with cystic fibrosis","volume":"7","author":"Edenborough","year":"2008","journal-title":"J Cyst Fibros Off J Eur Cyst Fibros Soc"},{"key":"10.1016\/j.jcte.2021.100289_b0435","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/pedi.12732","article-title":"ISPAD Clinical Practice Consensus Guidelines 2018: Management of cystic fibrosis-related diabetes in children and adolescents","volume":"19","author":"Moran","year":"2018","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/j.jcte.2021.100289_b0440","doi-asserted-by":"crossref","first-page":"S95","DOI":"10.1016\/j.jcf.2019.08.024","article-title":"Female reproductive health in cystic fibrosis","volume":"18","author":"Hughan","year":"2019","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcte.2021.100289_b0445","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1016\/j.jcf.2019.08.011","article-title":"Cystic fibrosis related diabetes: Nutrition and growth considerations","volume":"18","author":"Kaminski","year":"2019","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcte.2021.100289_b0450","doi-asserted-by":"crossref","unstructured":"Nutritional management of cystic fibrosis \u2013 an update for the 21st century. Paediatr Respir Rev 2018;26:4\u20136. https:\/\/doi.org\/10.1016\/j.prrv.2017.03.006.","DOI":"10.1016\/j.prrv.2017.03.006"},{"issue":"7","key":"10.1016\/j.jcte.2021.100289_b0455","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.2337\/dc17-2419","article-title":"Hemoglobin A1c Accurately Predicts Continuous Glucose Monitoring-Derived Average Glucose in Youth and Young Adults With Cystic Fibrosis","volume":"41","author":"Chan","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcte.2021.100289_b0460","doi-asserted-by":"crossref","unstructured":"ACOG Practice Bulletin No. 201: Pregestational Diabetes...\u00a0: Obstetrics & Gynecology. LWW n.d. https:\/\/doi.org\/10.1097\/AOG.0000000000002960.","DOI":"10.1097\/AOG.0000000000002960"},{"key":"10.1016\/j.jcte.2021.100289_b0465","doi-asserted-by":"crossref","unstructured":"ACOG Practice Bulletin No. 190: Gestational Diabetes Mellitus. Obstet Gynecol 2018;131:e49\u201364. https:\/\/doi.org\/10.1097\/AOG.0000000000002501.","DOI":"10.1097\/AOG.0000000000002501"},{"issue":"10110","key":"10.1016\/j.jcte.2021.100289_b0470","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1016\/S0140-6736(17)32400-5","article-title":"Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial","volume":"390","author":"Feig","year":"2017","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.jcte.2021.100289_b0475","doi-asserted-by":"crossref","unstructured":"Murphy HR, Rayman G, Lewis K, Kelly S, Johal B, Duffield K, et al. Effectiveness of continuous glucose monitoring in pregnant women with diabetes: randomised clinical trial. BMJ 2008;337:a1680. https:\/\/doi.org\/10.1136\/bmj.a1680.","DOI":"10.1136\/bmj.a1680"},{"issue":"7","key":"10.1016\/j.jcte.2021.100289_b0480","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1007\/s00125-019-4850-0","article-title":"Continuous glucose monitoring in pregnant women with type 1 diabetes: an observational cohort study of 186 pregnancies","volume":"62","author":"Kristensen","year":"2019","journal-title":"Diabetologia"},{"issue":"8","key":"10.1016\/j.jcte.2021.100289_b0485","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.2337\/dci19-0028","article-title":"Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range","volume":"42","author":"Battelino","year":"2019","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.jcte.2021.100289_b0490","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.2337\/dc08-1925","article-title":"Validation of continuous glucose monitoring in children and adolescents with cystic fibrosis: a prospective cohort study","volume":"32","author":"O'Riordan","year":"2009","journal-title":"Diabetes Care"},{"issue":"Suppl 2","key":"10.1016\/j.jcte.2021.100289_b0495","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1016\/j.jcf.2019.08.004","article-title":"Hypoglycemia in cystic fibrosis: Prevalence, impact and treatment","volume":"18","author":"Moheet","year":"2019","journal-title":"J Cyst Fibros Off J Eur Cyst Fibros Soc"},{"key":"10.1016\/j.jcte.2021.100289_b0500","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.jcf.2019.08.003","article-title":"Cystic fibrosis related diabetes: Medical management","volume":"18","author":"Ode","year":"2019","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcte.2021.100289_b0505","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1001\/jama.2019.4981","article-title":"Management of Preexisting Diabetes in Pregnancy: A Review","volume":"321","author":"Alexopoulos","year":"2019","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.jcte.2021.100289_b0510","doi-asserted-by":"crossref","first-page":"92","DOI":"10.2337\/diaspect.29.2.92","article-title":"Insulin Use in Pregnancy: An Update","volume":"29","author":"Blum","year":"2016","journal-title":"Diabetes Spectr"},{"issue":"3","key":"10.1016\/j.jcte.2021.100289_b0515","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jcf.2008.12.001","article-title":"Use of the insulin pump in treat cystic fibrosis related diabetes","volume":"8","author":"Hardin","year":"2009","journal-title":"J Cyst Fibros Off J Eur Cyst Fibros Soc"},{"issue":"1","key":"10.1016\/j.jcte.2021.100289_b0520","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/pedi.12158","article-title":"Why is insulin pump treatment rarely used in adolescents and young adults with cystic fibrosis-related diabetes?","volume":"16","author":"Scheuing","year":"2015","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/j.jcte.2021.100289_b0525","doi-asserted-by":"crossref","unstructured":"Marks BE, Kilberg MJ, Aliaj E, Fredkin K, Hudson J, Riva D, et al. Perceptions of Diabetes Technology Use in Cystic Fibrosis-Related Diabetes Management. Diabetes Technol Ther 2021. https:\/\/doi.org\/10.1089\/dia.2021.0201.","DOI":"10.1089\/dia.2021.0201"},{"issue":"4","key":"10.1016\/j.jcte.2021.100289_b0530","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s00125-014-3163-6","article-title":"Insulin pump use in pregnancy is associated with lower HbA1c without increasing the rate of severe hypoglycaemia or diabetic ketoacidosis in women with type 1 diabetes","volume":"57","author":"Kallas-Koeman","year":"2014","journal-title":"Diabetologia"},{"issue":"5","key":"10.1016\/j.jcte.2021.100289_b0535","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.diabet.2011.02.002","article-title":"Type 1 diabetes control and pregnancy outcomes in women treated with continuous subcutaneous insulin infusion (CSII) or with insulin glargine and multiple daily injections of rapid-acting insulin analogues (glargine-MDI)","volume":"37","author":"Bruttomesso","year":"2011","journal-title":"Diabetes Metab"},{"issue":"1","key":"10.1016\/j.jcte.2021.100289_b0540","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s00592-007-0239-5","article-title":"Outcome of pregnancy in women with type 1 diabetes intensively treated with continuous subcutaneous insulin infusion or conventional therapy. A case-control study","volume":"44","author":"Gim\u00e9nez","year":"2007","journal-title":"Acta Diabetol"},{"issue":"6","key":"10.1016\/j.jcte.2021.100289_b0545","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.2337\/dc19-2527","article-title":"CONCEPTT Collaborative Group. Continuous Glucose Monitoring in Pregnancy: Importance of Analyzing Temporal Profiles to Understand Clinical Outcomes","volume":"43","author":"Scott","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcte.2021.100289_b0550","doi-asserted-by":"crossref","unstructured":"Farrar D, Tuffnell DJ, West J, West HM. Continuous subcutaneous insulin infusion versus multiple daily injections of insulin for pregnant women with diabetes. Cochrane Database Syst Rev 2016:CD005542. https:\/\/doi.org\/10.1002\/14651858.CD005542.pub3.","DOI":"10.1002\/14651858.CD005542.pub3"},{"issue":"1","key":"10.1016\/j.jcte.2021.100289_b0555","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/dmrr.2653","article-title":"Continuous subcutaneous insulin infusion in diabetes: patient populations, safety, efficacy, and pharmacoeconomics","volume":"32","author":"Pozzilli","year":"2016","journal-title":"Diabetes Metab Res Rev"},{"issue":"12","key":"10.1016\/j.jcte.2021.100289_b0560","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.2337\/dc18-1437","article-title":"Pumps or Multiple Daily Injections in Pregnancy Involving Type 1 Diabetes: A Prespecified Analysis of the CONCEPTT Randomized Trial","volume":"41","author":"Feig","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcte.2021.100289_b0565","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1530\/EJE-17-0804","article-title":"Continuous subcutaneous insulin infusion vs multiple daily injections in pregnant women with type 1 diabetes mellitus: a systematic review and meta-analysis of randomised controlled trials and observational studies","volume":"178","author":"Rys","year":"2018","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"10.1016\/j.jcte.2021.100289_b0570","doi-asserted-by":"crossref","first-page":"194","DOI":"10.2337\/ds18-0091","article-title":"A Clinical Overview of Insulin Pump Therapy for the Management of Diabetes: Past, Present, and Future of Intensive Therapy","volume":"32","author":"Berget","year":"2019","journal-title":"Diabetes Spectr"},{"key":"10.1016\/j.jcte.2021.100289_b0575","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3389\/fendo.2018.00020","article-title":"Cystic Fibrosis-Related Diabetes","volume":"9","author":"Kayani","year":"2018","journal-title":"Front Endocrinol"},{"issue":"4","key":"10.1016\/j.jcte.2021.100289_b0580","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.jcf.2021.05.016","article-title":"Review of gastrointestinal motility in cystic fibrosis","volume":"20","author":"Henen","year":"2021","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcte.2021.100289_b0585","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1016\/j.jcf.2017.07.014","article-title":"Bacterial overgrowth, dysbiosis, inflammation, and dysmotility in the Cystic Fibrosis intestine","volume":"16","author":"Dorsey","year":"2017","journal-title":"J Cyst Fibros"}],"container-title":["Journal of Clinical & Translational Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214623721000417?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214623721000417?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,16]],"date-time":"2024-06-16T04:16:54Z","timestamp":1718511414000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214623721000417"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":117,"alternative-id":["S2214623721000417"],"URL":"https:\/\/doi.org\/10.1016\/j.jcte.2021.100289","relation":{},"ISSN":["2214-6237"],"issn-type":[{"value":"2214-6237","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gestational and pregestational diabetes in pregnant women with cystic fibrosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical & Translational Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcte.2021.100289","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100289"}}